Patrick John Jermain Sells 2,321 Shares of Plexus (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) CFO Patrick John Jermain sold 2,321 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $201.12, for a total transaction of $466,799.52. Following the completion of the transaction, the chief financial officer directly owned 14,561 shares of the company’s stock, valued at $2,928,508.32. This represents a 13.75% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Patrick John Jermain also recently made the following trade(s):

  • On Wednesday, February 4th, Patrick John Jermain sold 3,587 shares of Plexus stock. The shares were sold at an average price of $204.09, for a total value of $732,070.83.
  • On Tuesday, February 3rd, Patrick John Jermain sold 4,841 shares of Plexus stock. The stock was sold at an average price of $204.01, for a total value of $987,612.41.

Plexus Stock Performance

Shares of PLXS stock opened at $197.22 on Thursday. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 30.67 and a beta of 0.81. Plexus Corp. has a 1-year low of $103.43 and a 1-year high of $211.84. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The stock’s fifty day simple moving average is $174.11 and its 200-day simple moving average is $152.49.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.07 billion. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, sell-side analysts predict that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Analyst Ratings Changes

PLXS has been the subject of a number of research reports. Benchmark lifted their target price on shares of Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Needham & Company LLC boosted their target price on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Weiss Ratings raised Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, February 5th. Finally, Williams Trading set a $195.00 price target on Plexus in a report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $189.20.

Check Out Our Latest Stock Analysis on Plexus

Hedge Funds Weigh In On Plexus

Institutional investors have recently bought and sold shares of the stock. American Century Companies Inc. increased its holdings in shares of Plexus by 44.2% during the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after acquiring an additional 338,119 shares during the last quarter. Victory Capital Management Inc. boosted its position in Plexus by 130.0% during the fourth quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock worth $51,311,000 after purchasing an additional 197,283 shares during the period. MetLife Investment Management LLC grew its holdings in Plexus by 713.3% during the fourth quarter. MetLife Investment Management LLC now owns 126,971 shares of the technology company’s stock valued at $18,665,000 after purchasing an additional 111,360 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in shares of Plexus in the third quarter valued at approximately $12,509,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Plexus by 965.0% in the third quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock worth $11,704,000 after buying an additional 73,295 shares during the last quarter. 94.45% of the stock is currently owned by institutional investors.

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

See Also

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.